Smart Nanozymes for Cancer Therapy: The Next Frontier in Oncology

Abstract

Nanomaterials that mimic the catalytic activity of natural enzymes in the complex biological environment of the human body are called nanozymes. Recently, nanozyme systems have been reported with diagnostic, imaging, and/or therapeutic capabilities. Smart nanozymes strategically exploit the tumor microenvironment (TME) by the in situ generation of reactive species or by the modulation of the TME itself to result in effective cancer therapy. This topical review focuses on such smart nanozymes for cancer diagnosis, and therapy modalities with enhanced therapeutic effects. The dominant factors that guide the rational design and synthesis of nanozymes for cancer therapy include an understanding of the dynamic TME, structure‐activity relationships, surface chemistry for imparting selectivity, and site‐specific therapy, and stimulus‐responsive modulation of nanozyme activity. This article presents a comprehensive analysis of the subject including the diverse catalytic mechanisms of different types of nanozyme systems, an overview of the TME, cancer diagnosis, and synergistic cancer therapies. The strategic application of nanozymes in cancer treatment can well be a game changer in future oncology. Moreover, recent developments may pave the way for the deployment of nanozyme therapy into other complex healthcare challenges, such as genetic diseases, immune disorders, and ageing.

ROS-Responsive Bola-Lipid Nanoparticles as a Codelivery System for Gene/Photodynamic Combination Therapy

“…ROS Response of the Compound N-TDZn. ROSinduced n-TDZn decomposition has been demonstrated by 1 H NMR, HR-MS, and Ellman's test in the previous report. 50 Herein, the ROS responsiveness of n-TDZn lipoplexes in terms of DNA release was evaluated by a gel retardation experiment.…”

“…Cancer has long been one of the deadliest diseases threatening human life. − Due to the complexity, diversity, and heterogeneity of tumors, traditional treatment methods have limited treatment efficiency and cannot completely cure cancer in most cases . In recent years, the progress of cancer treatment has gradually shifted from monotherapy to the combination of multiple treatment methods. , This multimodal therapy refers to the combination of two or more medical approaches such as surgery, chemotherapy (CT), , radiotherapy (RT), , high-intensity focused ultrasound (HIFU), gene therapy, , photodynamic therapy (PDT), , photothermal therapy (PTT), , and immunotherapy. , Different from monotherapy, multimodal treatments have the characteristics of reducing drug dose, enhancing efficacy, and fewer side effects, showing much higher promise for the antitumor therapy. , …”

Transition-Metal-Based Nanozymes: Synthesis, Mechanisms of Therapeutic Action, and Applications in Cancer Treatment

“…Furthermore, the activity of transition-metal-based nanozymes is influenced not only by their inherent characteristics such as size, shape, and valence state but also by environmental stimuli including endogenous and exogenous factors . Additionally, transition-metal-based nanozymes exhibit the ability to reverse the TME by performing a range of enzyme-like activities, including catalyzing O 2 generation, promoting GSH consumption, accelerating ROS accumulation, and thereby achieving antitumor effects. − …”

Disruption of Communication: Recent Advances in Antibiofilm Materials with Anti-Quorum Sensing Properties

“…In recent years, nanozymes have garnered extensive attention within the field of biomedicine due to their remarkable catalytic activity, high stability, cost-effectiveness, and ease of modification. − Among these nanozymes, the CeO 2 nanozyme exhibits haloperoxidase-like characteristics, catalyzing the conversion of hydrogen peroxide and Br − into HOBr. The presence of hypohalous acids, such as HOBr, is known to disrupt QS in microorganismsa regulatory process utilized by cells and bacteria to control biofilm formation.…”